[ad_1]
Nearly half of U.S. adults are struggling to cover the cost of prescription drugs and doctor visits, new research shows, marking a new low for healthcare affordability.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...